Research & Literature

Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.

Holl K, Nowakowski AM, Powell N, et al.

International journal of cancer 2015; (137(12)):2858-68 doi:10.1002/ijc.29651.

Surveillance and Care of the Gynecologic Cancer Survivor.

Faubion SS, MacLaughlin KL, Long ME, et al.

Journal of women's health (2002) 2015; (24(11)):899-906 doi:10.1089/jwh.2014.5127.

[Follow-up after radiation therapy for cervical cancer].

Cao KI, Mazeron R, Barillot I

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2015; (19(6-7)):590-6.

Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life.

Iyer NS, Osann K, Hsieh S, et al.

Clinical therapeutics 2016; (38(3)):467-75.

Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations.

Hendry M, Pasterfield D, Adams R, et al.

BMJ open 2016; (6(4)):e011205 doi:10.1136/bmjopen-2016-011205.

Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update.

Elit L, Kennedy EB, Fyles A, Metser U

Current oncology (Toronto, Ont.) 2016; (23(2)):109-18 doi:10.3747/co.23.2742.

Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists.

Gadducci A, Carinelli S, Aletti G

Gynecologic oncology 2017; (144(3)):637-646 doi:10.1016/j.ygyno.2016.12.003.

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

Tewari KS, Sill MW, Penson RT, et al.

Lancet (London, England) 2017; (390(10103)):1654-1663 doi:10.1016/S0140-6736(17)31607-0.

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Denlinger CS, Sanft T, Baker KS, et al.

Journal of the National Comprehensive Cancer Network : JNCCN 2017; (15(9)):1140-1163 doi:10.6004/jnccn.2017.0146.

Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG).

Luo HC, Lin GS, Liao SG, et al.

The British journal of radiology 2018; (91(1081)):20170398 doi:10.1259/bjr.20170398.

Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.

Kojima A, Shimada M, Mikami Y, et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2018; (28(1)):99-106 doi:10.1097/IGC.0000000000001145.

The developing spectrum of gastric-type cervical glandular lesions.

Talia KL, McCluggage WG

Pathology 2018; (50(2)):122-133 doi:10.1016/j.pathol.2017.09.009.

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.

Ramirez PT, Frumovitz M, Pareja R, et al.

The New England journal of medicine 2018; (379(20)):1895-1904 doi:10.1056/NEJMoa1806395.

Sexual quality of life in men and women after cancer.

Schover LR

Climacteric : the journal of the International Menopause Society 2019; (22(6)):553-557 doi:10.1080/13697137.2018.1526893.

Revised FIGO staging for carcinoma of the cervix uteri.

Bhatla N, Berek JS, Cuello Fredes M, et al.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2019; (145(1)):129-135 doi:10.1002/ijgo.12749.

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors.

Shay LA, Schmidt S, Dioun SI, et al.

Journal of cancer survivorship : research and practice 2019; (13(2)):180-186 doi:10.1007/s11764-019-00740-6.

[Focus on mucinous adenocarcinoma of the uterine cervix].

Bonin L, Devouassoux-Shisheboran M, Golfier F

Gynecologie, obstetrique, fertilite & senologie 2019; (47(4)):352-361 doi:10.1016/j.gofs.2019.02.006.

Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.

Gadducci A, Guerrieri ME, Cosio S

Critical reviews in oncology/hematology 2019; (135()):103-114 doi:10.1016/j.critrevonc.2019.01.006.

Smoking Cessation Treatment Needs of Low SES Cervical Cancer Survivors.

Hoover DS, Spears CA, Vidrine DJ, et al.

American journal of health behavior 2019; (43(3)):606-620 doi:10.5993/AJHB.43.3.14.

Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.

Wright JD, Matsuo K, Huang Y, et al.

Obstetrics and gynecology 2019; (134(1)):49-57 doi:10.1097/AOG.0000000000003311.

Recent advances in invasive adenocarcinoma of the cervix.

Stolnicu S, Hoang L, Soslow RA

Virchows Archiv : an international journal of pathology 2019; (475(5)):537-549 doi:10.1007/s00428-019-02601-0.

Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.

Sehnal B, Kmoníčková E, Sláma J, et al.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019; (32(3)):224-231 doi:10.14735/amko2019224.

What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?

Haldorsen IS, Lura N, Blaakær J, et al.

Current oncology reports 2019; (21(9)):77 doi:10.1007/s11912-019-0824-0.

Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.

Vonsky M, Shabaeva M, Runov A, et al.

Biochemistry. Biokhimiia 2019; (84(7)):782-799 doi:10.1134/S0006297919070095.

Prognostic value of lymphovascular space invasion in patients with early stage cervical cancer in Jilin, China: A retrospective study.

Yan W, Qiu S, Ding Y, et al.

Medicine 2019; (98(40)):e17301 doi:10.1097/MD.0000000000017301.

High-dose-rate intracavitary brachytherapy for recurrent cervical cancer in the vaginal stump after hysterectomy.

Kozai Y, Itoh Y, Kawamura M, et al.

Nagoya journal of medical science 2019; (81(3)):351-358 doi:10.18999/nagjms.81.3.351.

FDG-PET Imaging in Cervical Cancer.

Gandy N, Arshad MA, Park WE, et al.

Seminars in nuclear medicine 2019; (49(6)):461-470 doi:10.1053/j.semnuclmed.2019.06.007.

Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.

Salcedo MP, Sood AK, Jhingran A, et al.

Cancer 2020; (126(11)):2607-2613 doi:10.1002/cncr.32807.

Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging.

Saleh M, Virarkar M, Javadi S, et al.

AJR. American journal of roentgenology 2020; (214(5)):1182-1195 doi:10.2214/AJR.19.21819.

Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.

Woo S, Atun R, Ward ZJ, et al.

European radiology 2020; (30(10)):5560-5577 doi:10.1007/s00330-020-06909-3.

Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?

Plante M, Renaud MC, Sebastianelli A, Gregoire J

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(7)):981-986 doi:10.1136/ijgc-2020-001432.

Multimodality Imaging of Uterine Cervical Malignancies.

Mansoori B, Khatri G, Rivera-Colón G, et al.

AJR. American journal of roentgenology 2020; (215(2)):292-304 doi:10.2214/AJR.19.21941.

A systematic review of the impact of contemporary treatment modalities for cervical cancer on women's self-reported health-related quality of life.

Wiltink LM, King M, Müller F, et al.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2020; (28(10)):4627-4644 doi:10.1007/s00520-020-05554-2.

[Reporting and handling of lymphonodectomy specimens in gynecologic malignancies and sentinel lymph nodes].

Höhn AK, Brambs CE, Erber R, et al.

Der Pathologe 2021; (42(3)):319-327 doi:10.1007/s00292-020-00805-9.

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.

Redondo A, Colombo N, McCormack M, et al.

Gynecologic oncology 2020; (159(1)):142-149 doi:10.1016/j.ygyno.2020.07.026.

Biological and clinical aspects of HPV-related cancers.

Szymonowicz KA, Chen J

Cancer biology & medicine 2020; (17(4)):864-878 doi:10.20892/j.issn.2095-3941.2020.0370.

Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort Study.

Chao X, Fan J, Song X, et al.

Frontiers in oncology 2020; (10()):591253 doi:10.3389/fonc.2020.591253.

Premature ovarian insufficiency: a toolkit for the primary care physician.

Lambrinoudaki I, Paschou SA, Lumsden MA, et al.

Climacteric : the journal of the International Menopause Society 2021; (24(5)):425-437 doi:10.1080/13697137.2020.1859246.

Diagnostic efficiency of whole-body 18F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer.

Steiner A, Narva S, Rinta-Kiikka I, et al.

Cancer imaging : the official publication of the International Cancer Imaging Society 2021; (21(1)):16 doi:10.1186/s40644-020-00372-5.

Diagnostic Methods for Vaginal Stenosis and Compliance to Vaginal Dilator Use: A Systematic Review.

Haddad NC, Soares Brollo LC, Pinho Oliveira MA, Bernardo-Filho M

The journal of sexual medicine 2021; (18(3)):493-514 doi:10.1016/j.jsxm.2020.12.013.

Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists.

Stolnicu S, Park KJ, Kiyokawa T, et al.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2021; (40(Suppl 1)):S75-S91 doi:10.1097/PGP.0000000000000751.

Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.

Chuai Y, Rizzuto I, Zhang X, et al.

The Cochrane database of systematic reviews 2021; (3()):CD013348 doi:10.1002/14651858.CD013348.pub2.

Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review.

Xing B, Guo J, Sheng Y, et al.

Frontiers in oncology 2020; (10()):606335 doi:10.3389/fonc.2020.606335.

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.

Coleman RL, Lorusso D, Gennigens C, et al.

The Lancet. Oncology 2021; (22(5)):609-619 doi:10.1016/S1470-2045(21)00056-5.

Interventions Preventing Vaginitis, Vaginal Atrophy after Brachytherapy or Radiotherapy Due to Malignant Tumors of the Female Reproductive Organs-A Systematic Review.

Wierzbicka A, Mańkowska-Wierzbicka D, Cieślewicz S, et al.

International journal of environmental research and public health 2021; (18(8)) doi:10.3390/ijerph18083932.

Quality of life in long term survivors of cervical cancer: A cross sectional study.

Shylasree TS, Ranade R, Kattepur AK, et al.

Indian journal of cancer 2021; (58(2)):171-178 doi:10.4103/ijc.IJC_712_18.

The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.

Ronsini C, Anchora LP, Restaino S, et al.

Gynecologic oncology 2021; (162(2)):299-307 doi:10.1016/j.ygyno.2021.06.002.

ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.

Schmeler KM, Pareja R, Lopez Blanco A, et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2021; (31(10)):1317-1325 doi:10.1136/ijgc-2021-002921.

Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical Hysterectomy.

Röseler J, Wolff R, Bauerschlag DO, et al.

Journal of clinical medicine 2021; (10(17)) doi:10.3390/jcm10173761.

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.

Colombo N, Dubot C, Lorusso D, et al.

The New England journal of medicine 2021; (385(20)):1856-1867 doi:10.1056/NEJMoa2112435.

Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.

Korenaga TK, Yoshida EJ, Pierson W, et al.

Gynecologic oncology 2022; (164(2)):348-356 doi:10.1016/j.ygyno.2021.11.015.

PET-CT versus MRI in the diagnosis of lymph node metastasis of cervical cancer: A meta-analysis.

He T, Sun J, Wu J, et al.

Microscopy research and technique 2022; (85(5)):1791-1798 doi:10.1002/jemt.24039.

Utility of routine cytology in detecting asymptomatic cervical cancer recurrence.

McDowell JL, Young AJ, Daucher JA, Purinton SC

Journal of the American Society of Cytopathology 2022; (11(3)):173-179 doi:10.1016/j.jasc.2021.12.004.

Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.

Kang S, Wu J, Li J, et al.

Medical science monitor : international medical journal of experimental and clinical research 2022; (28()):e934588 doi:10.12659/MSM.934588.

Mitigation and management strategies for ocular events associated with tisotumab vedotin.

Kim SK, Ursell P, Coleman RL, et al.

Gynecologic oncology 2022; (165(2)):385-392 doi:10.1016/j.ygyno.2022.02.010.

Multimodality treatment for multiple recurrences of cervical cancer after radiotherapy: a case report.

Wang Z, Ren X, Liu Z, et al.

Translational cancer research 2022; (11(4)):943-951 doi:10.21037/tcr-21-2250.

Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001).

Hwang WY, Chang SJ, Kim HS, et al.

BMC cancer 2022; (22(1)):603 doi:10.1186/s12885-022-09695-x.

Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.

Sugiyama T, Katsumata N, Toita T, et al.

International journal of clinical oncology 2022; (27(9)):1517-1528 doi:10.1007/s10147-022-02196-8.

What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines.

Rives N, Courbière B, Almont T, et al.

European journal of cancer (Oxford, England : 1990) 2022; (173()):146-166 doi:10.1016/j.ejca.2022.05.013.

The Association between Survivorship Care Plans and Patient-Reported Satisfaction and Confidence with Follow-Up Cancer Care Provided by Primary Care Providers.

Chu AK, Mutsaers B, Lebel S

Current oncology (Toronto, Ont.) 2022; (29(10)):7343-7354 doi:10.3390/curroncol29100577.

Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Park KJ, Selinger CI, Alvarado-Cabrero I, et al.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2022; (41(Suppl 1)):S64-S89 doi:10.1097/PGP.0000000000000909.

A review of the novel tissue factor antibody-drug conjugate: Tisotumab vedotin.

Luu K, Chu A, Chang B

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2023; (29(2)):441-449 doi:10.1177/10781552221139775.

Fatal rectovaginal fistula in post-radiotherapy locally advanced cervical cancer patients.

Wu CY, Tseng LM, Chen HH, et al.

Taiwanese journal of obstetrics & gynecology 2022; (61(6)):1069-1072 doi:10.1016/j.tjog.2022.01.007.

Barriers to and strategies for dealing with vaginal dilator therapy - Female pelvic cancer survivors' experiences: A qualitative study.

Åkeflo L, Elmerstig E, Bergmark K, Dunberger G

European journal of oncology nursing : the official journal of European Oncology Nursing Society 2023; (62()):102252 doi:10.1016/j.ejon.2022.102252.

Tisotumab Vedotin Safety and Tolerability in Clinical Practice: Managing Adverse Events.

Arn CR, Halla KJ, Gill S

Journal of the advanced practitioner in oncology 2023; (14(2)):139-152 doi:10.6004/jadpro.2023.14.2.4.

Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions.

Stolnicu S, Allison D, Patrichi A, et al.

Advances in anatomic pathology 2024; (31(1)):1-14 doi:10.1097/PAP.0000000000000411.

Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer.

Fehm T, Beckmann MW, Mahner S, et al.

Geburtshilfe und Frauenheilkunde 2023; (83(10)):1199-1204 doi:10.1055/a-2160-3279.

Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications.

Salman L, Covens A

Current oncology (Toronto, Ont.) 2024; (31(1)):296-306 doi:10.3390/curroncol31010019.

The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023).

Fischerova D, Frühauf F, Burgetova A, et al.

Cancers 2024; (16(4)) doi:10.3390/cancers16040775.

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.

Plante M, Kwon JS, Ferguson S, et al.

The New England journal of medicine 2024; (390(9)):819-829 doi:10.1056/NEJMoa2308900.

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.

Lorusso D, Xiang Y, Hasegawa K, et al.

Lancet (London, England) 2024; (403(10434)):1341-1350 doi:10.1016/S0140-6736(24)00317-9.

Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience.

Danisch M, Kranawetter M, Bartl T, et al.

Journal of personalized medicine 2024; (14(6)) doi:10.3390/jpm14060611.

Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.

Vergote I, González-Martín A, Fujiwara K, et al.

The New England journal of medicine 2024; (391(1)):44-55 doi:10.1056/NEJMoa2313811.

Patient-reported sexual health outcomes of cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy.

Chuk E, Conway JL, Hanuschak J, et al.

Gynecologic oncology 2024; (190()):153-159 doi:10.1016/j.ygyno.2024.08.022.

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Lorusso D, Xiang Y, Hasegawa K, et al.

Lancet (London, England) 2024; (404(10460)):1321-1332 doi:10.1016/S0140-6736(24)01808-7.

Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.

Kwon JS, McTaggart-Cowan H, Ferguson SE, et al.

Journal of gynecologic oncology 2024; (35(6)):e117 doi:10.3802/jgo.2024.35.e117.

The Natural History of Cervical Cancer and the Case for MicroRNAs: Is Human Papillomavirus Infection the Whole Story?

Palomino-Vizcaino G, Bañuelos-Villegas EG, Alvarez-Salas LM

International journal of molecular sciences 2024; (25(23)) doi:10.3390/ijms252312991.

Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion.

Bizzarri N, Kyrgiou M, De Vincenzo R, et al.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025; (169(2)):597-604 doi:10.1002/ijgo.16120.

Ocular surface disease related to tisotumab vedotin-tftv.

Lent-Schochet D, Tauber S, Seagrave Z, et al.

Gynecologic oncology reports 2025; (57()):101676 doi:10.1016/j.gore.2025.101676.

The Impact of Chronic Pelvic Pain and Bowel Morbidity on Quality of Life in Cervical Cancer Patients Treated With Radio (Chemo) Therapy. A Systematic Literature Review.

Natuhwera G, Ellis P

Journal of pain research 2025; (18()):597-618 doi:10.2147/JPR.S501378.

Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment.

Kamzayeva N, Bapayeva G, Terzic M, et al.

Life (Basel, Switzerland) 2025; (15(3)) doi:10.3390/life15030367.

Novel ultrasound features and diagnostic clues of gastric-type endocervical adenocarcinoma: a case series.

Yang L, Wang Y, Cai J, et al.

Frontiers in oncology 2025; (15()):1572438 doi:10.3389/fonc.2025.1572438.

Impact of Patient Selection on Real-World Outcomes by Using the EMBRACE-II Treatment Protocol in Locally Advanced Cervical Cancer.

Lindegaard JC, Kirisits C, Schmid MP, et al.

International journal of radiation oncology, biology, physics 2025; (123(3)):669-680 doi:10.1016/j.ijrobp.2025.05.068.

2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns.

Bhinder JK, Kennedy SKF, Faouk Al Aadah C, Al-Khaifi M

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025; (33(7)):584 doi:10.1007/s00520-025-09640-1.

Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.

Randall L, Xiang Y, Matsumoto T, et al.

Gynecologic oncology 2025; (199()):88-95 doi:10.1016/j.ygyno.2025.06.003.

Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial.

Cibula D, Marnitz S, Jarkovský J, et al.

Nature cancer 2025; (6(9)):1585-1594 doi:10.1038/s43018-025-01016-y.

Current Updates on Surgical Management of Patients with Early-Stage Cervical Cancer.

Santía MC, Meschini T, Hsu HC, et al.

Cancers 2025; (17(13)) doi:10.3390/cancers17132259.

Cervical Cancer Treatment and Fertility: What We Know and What We Do.

Habib N, Idoubba S, Futcher F, et al.

Cancers 2025; (17(18)) doi:10.3390/cancers17183057.

Fertility-Sparing Trachelectomy With Sentinel Node Mapping in Early-Stage Cervical Cancer: Oncological Safety and Obstetric Outcomes From a Single-Institution Study.

Togami S, Furuzono N, Kobayashi Y, et al.

The journal of obstetrics and gynaecology research 2025; (51(10)):e70091 doi:10.1111/jog.70091.

Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.

Tu H, Huang H, Li Y, et al.

The New England journal of medicine 2025; (393(15)):1463-1474 doi:10.1056/NEJMoa2506267.

HPV-Independent Cervical Cancer-A New Challenge of Modern Oncology.

Hurjui RM, Hurjui IA, Buțureanu TA, et al.

International journal of molecular sciences 2025; (26(20)) doi:10.3390/ijms262010051.

Prenatal diagnosis and management of high-grade cervical neuroendocrine carcinoma: A case report.

Rodríguez JSJ, Hernández JA, Gallego PA, Sarmiento CDR

Case reports in women's health 2025; (48()):e00760 doi:10.1016/j.crwh.2025.e00760.

Lymphoepithelioma epidermoid carcinoma of the uterine cervix: surgical management of an isolated case and review of the literature.

Tenazoa-Villalobos JR, Yan-Quiroz EF, Ordoñez-Chinguel A, et al.

Ecancermedicalscience 2025; (19()):1974 doi:10.3332/ecancer.2025.1974.

Molecular, immunological and oncogenic mechanisms of cervical cancer mediated by HPV/HIV co-infection, clinical implication and management.

Terkimbi SD, Paul-Chima UO, Mujinya R, et al.

Infectious agents and cancer 2025; (21(1)):12 doi:10.1186/s13027-025-00729-0.

Radiation therapy for cervical cancer in Uganda: a practice guideline.

Kibudde S, Kavuma A, Abal B, et al.

Ecancermedicalscience 2025; (19()):1999 doi:10.3332/ecancer.2025.1999.

Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging strategies.

Gholami S, Aghbash PS, Ravanlo ZZ, et al.

International immunopharmacology 2026; (172()):116193 doi:10.1016/j.intimp.2026.116193.

CT versus MRI for Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: A Propensity Score-Matched Analysis.

Nagar A, Samanta A, Chopra S, et al.

International journal of radiation oncology, biology, physics 2026; (125(4)):1111-1120 doi:10.1016/j.ijrobp.2026.01.041.

De-escalation in definitive surgical management for cervical cancer.

Viveros-Carreño D, Agustí N, Mora-Soto N, et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2025; 102711 doi:10.1016/j.ijgc.2025.102711.

Radiotherapy effects on the lower urinary tract: A review of long-term complications and their management.

Sarafis ACE, Locke J

Urologia 2026; (93(3)):325-337 doi:10.1177/03915603261426607.

American Brachytherapy Society Working Group Report on cancer surveillance, sexual health, and pelvic toxicity management in gynecologic malignancies.

Quick A, Garda A, Rivera A, et al.

Brachytherapy 2026; (25(4)):559-568 doi:10.1016/j.brachy.2026.03.010.

HPV-related cancer prevention in Spain: progress and remaining challenges in vaccination, screening, and surveillance.

Martínez AG, Gonzalez-Martin A, de Agustin LC

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; doi:10.1007/s12094-026-04447-w.

Risk Factors for Sacral Insufficiency Fracture After Pelvic Irradiation for Cervical Cancer.

Saito M, Hasegawa T, Ohtani A, et al.

In vivo (Athens, Greece) 2026; (40(4)):2436-2444 doi:10.21873/invivo.14397.

Co-production of a conversation guide for HPV-based cervical cancer screening results communication.

Danan ER, Woodward-Abel AB, Gowdy-Jaehnig A, et al.

Patient education and counseling 2026; (152()):109809 doi:10.1016/j.pec.2026.109809.

Initial evaluation of cervical cancer: A literature review of staging conization for accurate risk stratification and guidance of primary treatment in early-stage disease - A review from the French cervical cancer guidelines group.

Chlala W, Favier A, Carcopino X, et al.

Journal of gynecology obstetrics and human reproduction 2026; (55(9)):103274 doi:10.1016/j.jogoh.2026.103274.

Pembrolizumab Plus Chemotherapy for Cervical Cancer: An Exploratory Analysis of the KEYNOTE-826 Randomized Clinical Trial.

Hasegawa K, Colombo N, Tewari KS, et al.

JAMA oncology 2026; doi:10.1001/jamaoncol.2026.3547.